Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa

Clinical trial NCT06555328 · TERMINATED

Trial details

NCT number: NCT06555328
Sponsor: InflaRx GmbH
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Urticaria, Idiopathic Hidradenitis Hidradenitis Suppurativa

Start date: 2025-01-02
Primary completion: 2026-01-22
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.